Recent Advances in Nanotherapeutics for Multiple Myeloma

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Cancer treatment requires personalized approaches, moving beyond one-size-fits-all strategies.
• Target-specific therapeutics are crucial for effective cancer management.
• Nanotherapeutics integrate molecular imaging and therapy for enhanced disease management.

Purpose of the Study:

• To review recent advancements in nanoparticle-based systems for multiple myeloma (MM) treatment.
• To explore functionalization methods, biocompatibility, and anticancer activity of these nanotherapeutics.
• To highlight the potential of nanotechnology in overcoming challenges in MM drug delivery.

Main Methods:

• Literature review of recent research on nanoparticle-based therapies for MM.
• Analysis of studies focusing on nanoparticle functionalization techniques.
• Evaluation of research on the biocompatibility and in vitro/in vivo anticancer efficacy of nanotherapeutics.

Main Results:

• Nanoparticle-based systems show significant promise for targeted MM therapy.
• Functionalization strategies enhance nanoparticle targeting and drug delivery efficiency.
• Nanotherapeutics demonstrate improved biocompatibility and anticancer activity compared to conventional treatments.

Conclusions:

• Nanotherapeutics represent a promising frontier for personalized multiple myeloma treatment.
• Nanotechnology offers solutions for targeted drug delivery and overcoming bioavailability issues in MM therapy.
• Further research into functionalization and biocompatibility will optimize nanotherapeutic efficacy for MM patients.